1. Home
  2. NOK vs BNTX Comparison

NOK vs BNTX Comparison

Compare NOK & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nokia Corporation Sponsored

NOK

Nokia Corporation Sponsored

HOLD

Current Price

$6.50

Market Cap

36.1B

Sector

Technology

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$96.50

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOK
BNTX
Founded
1865
2008
Country
Finland
Germany
Employees
78434
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.1B
24.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
NOK
BNTX
Price
$6.50
$96.50
Analyst Decision
Strong Buy
Buy
Analyst Count
3
11
Target Price
$7.50
$137.40
AVG Volume (30 Days)
18.3M
1.2M
Earning Date
01-29-2026
11-03-2025
Dividend Yield
1.61%
N/A
EPS Growth
129.18
N/A
EPS
0.20
N/A
Revenue
$23,170,245,221.00
$3,698,814,972.00
Revenue This Year
$6.58
$2.03
Revenue Next Year
$3.98
N/A
P/E Ratio
$33.30
N/A
Revenue Growth
5.88
3.70
52 Week Low
$4.00
$81.20
52 Week High
$8.19
$129.27

Technical Indicators

Market Signals
Indicator
NOK
BNTX
Relative Strength Index (RSI) 56.20 51.70
Support Level $6.46 $94.00
Resistance Level $6.62 $95.71
Average True Range (ATR) 0.11 1.72
MACD 0.01 0.62
Stochastic Oscillator 62.73 81.33

Price Performance

Historical Comparison
NOK
BNTX

About NOK Nokia Corporation Sponsored

Nokia provides telecom equipment and services that are used to build wireless and fixed-line networks. It operates in four segments. The mobile networks segment sells equipment and services to telecom carriers to power public wireless networks. Network infrastructure focuses on fixed-line networks, including switching and routing equipment, optical components, and devices used in fiber-to-the-premises networks. The cloud and network services segment develops software used to operate the core of carrier wireless networks and build private networks for enterprises. Nokia also has a sizable research and patent business, where it licenses technology used by handset providers, consumer electronics firms, and other firms making electronic and Internet of Things products.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: